- Home
- NDLS vs TURN Comparison
NDLS vs TURN Comparison
Compare NDLS & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDLS
- TURN
- Stock Information
- Founded
- NDLS 1995
- TURN 1981
- Country
- NDLS United States
- TURN United States
- Employees
- NDLS N/A
- TURN N/A
- Industry
- NDLS Restaurants
- TURN Finance/Investors Services
- Sector
- NDLS Consumer Discretionary
- TURN Finance
- Exchange
- NDLS Nasdaq
- TURN Nasdaq
- Market Cap
- NDLS 34.3M
- TURN 39.6M
- IPO Year
- NDLS 2013
- TURN N/A
- Fundamental
- Price
- NDLS $1.42
- TURN $3.79
- Analyst Decision
- NDLS Strong Buy
- TURN
- Analyst Count
- NDLS 2
- TURN 0
- Target Price
- NDLS $3.00
- TURN N/A
- AVG Volume (30 Days)
- NDLS 163.8K
- TURN 39.6K
- Earning Date
- NDLS 03-06-2025
- TURN 03-18-2025
- Dividend Yield
- NDLS N/A
- TURN N/A
- EPS Growth
- NDLS N/A
- TURN N/A
- EPS
- NDLS N/A
- TURN N/A
- Revenue
- NDLS $493,271,000.00
- TURN $194,813.00
- Revenue This Year
- NDLS $0.28
- TURN N/A
- Revenue Next Year
- NDLS N/A
- TURN N/A
- P/E Ratio
- NDLS N/A
- TURN N/A
- Revenue Growth
- NDLS N/A
- TURN 254.25
- 52 Week Low
- NDLS $0.55
- TURN $3.12
- 52 Week High
- NDLS $2.36
- TURN $4.46
- Technical
- Relative Strength Index (RSI)
- NDLS 51.85
- TURN 35.71
- Support Level
- NDLS $1.27
- TURN $3.95
- Resistance Level
- NDLS $1.57
- TURN $4.05
- Average True Range (ATR)
- NDLS 0.14
- TURN 0.09
- MACD
- NDLS -0.04
- TURN -0.04
- Stochastic Oscillator
- NDLS 39.81
- TURN 2.38
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.